Kronos Bio Performance

KRONDelisted Stock  USD 0.88  0.00  0.00%   
The company secures a Beta (Market Risk) of -0.4, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Kronos Bio are expected to decrease at a much lower rate. During the bear market, Kronos Bio is likely to outperform the market. Kronos Bio right now secures a risk of 0.0%. Please verify Kronos Bio maximum drawdown, as well as the relationship between the expected short fall and day median price , to decide if Kronos Bio will be following its current price movements.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Kronos Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Kronos Bio is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors. ...more
  

Kronos Bio Relative Risk vs. Return Landscape

If you would invest  88.00  in Kronos Bio on November 9, 2025 and sell it today you would earn a total of  0.00  from holding Kronos Bio or generate 0.0% return on investment over 90 days. Kronos Bio is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Kronos, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  

Kronos Bio Target Price Odds to finish over Current Price

The tendency of Kronos Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.88 90 days 0.88 
about 17.39
Based on a normal probability distribution, the odds of Kronos Bio to move above the current price in 90 days from now is about 17.39 (This Kronos Bio probability density function shows the probability of Kronos Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Kronos Bio has a beta of -0.4. This indicates as returns on the benchmark increase, returns on holding Kronos Bio are expected to decrease at a much lower rate. During a bear market, however, Kronos Bio is likely to outperform the market. Additionally Kronos Bio has an alpha of 0.0584, implying that it can generate a 0.0584 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Kronos Bio Price Density   
       Price  

Predictive Modules for Kronos Bio

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Kronos Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.880.880.88
Details
Intrinsic
Valuation
LowRealHigh
0.710.710.97
Details
Naive
Forecast
LowNextHigh
0.820.820.82
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.610.790.97
Details

Kronos Bio Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Kronos Bio is not an exception. The market had few large corrections towards the Kronos Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Kronos Bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Kronos Bio within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.06
β
Beta against Dow Jones-0.4
σ
Overall volatility
0.09
Ir
Information ratio -0.01

Kronos Bio Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Kronos Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Kronos Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Kronos Bio is not yet fully synchronised with the market data
Kronos Bio has some characteristics of a very speculative penny stock
Kronos Bio has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 9.85 M. Net Loss for the year was (86.08 M) with profit before overhead, payroll, taxes, and interest of 9.19 M.
Kronos Bio currently holds about 267.89 M in cash with (65.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.72, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 24.0% of the company outstanding shares are owned by corporate insiders

Kronos Bio Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Kronos Stock often depends not only on the future outlook of the current and potential Kronos Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kronos Bio's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding60.1 M
Cash And Short Term Investments112.4 M

Kronos Bio Fundamentals Growth

Kronos Stock prices reflect investors' perceptions of the future prospects and financial health of Kronos Bio, and Kronos Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Kronos Stock performance.

About Kronos Bio Performance

By examining Kronos Bio's fundamental ratios, stakeholders can obtain critical insights into Kronos Bio's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Kronos Bio is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company was incorporated in 2017 and is headquartered in San Mateo, California. Kronos Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 101 people.

Things to note about Kronos Bio performance evaluation

Checking the ongoing alerts about Kronos Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Kronos Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Kronos Bio is not yet fully synchronised with the market data
Kronos Bio has some characteristics of a very speculative penny stock
Kronos Bio has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 9.85 M. Net Loss for the year was (86.08 M) with profit before overhead, payroll, taxes, and interest of 9.19 M.
Kronos Bio currently holds about 267.89 M in cash with (65.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.72, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 24.0% of the company outstanding shares are owned by corporate insiders
Evaluating Kronos Bio's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Kronos Bio's stock performance include:
  • Analyzing Kronos Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Kronos Bio's stock is overvalued or undervalued compared to its peers.
  • Examining Kronos Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Kronos Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Kronos Bio's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Kronos Bio's stock. These opinions can provide insight into Kronos Bio's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Kronos Bio's stock performance is not an exact science, and many factors can impact Kronos Bio's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Consideration for investing in Kronos Stock

If you are still planning to invest in Kronos Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kronos Bio's history and understand the potential risks before investing.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities